Janus kinase (JAK) inhibitors are not associated with an increased risk for gastrointestinal perforation (GIP) among patients with rheumatoid arthritis (RA), according to study results published in ...

The FDA has granted Fast Track designation to TEV-53408, an investigational anti-interleukin-15 antibody, for the treatment of celiac disease.

Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders.

Women residing in US neighborhoods with high social vulnerability have a higher risk for earlier natural menopause.

Among older adults who sustained a hip fracture, a significant proportion demonstrated varying levels of resilience across different HRQOL domains.

The association of low-carbohydrate (LCD) and low-fat diets (LFD) with coronary heart disease (CHD) risk depends on the quality of macronutrients.

Intravenous ibuprofen appears safe and effective for older adults, reducing postoperative pain and opioid consumption.

The FDA has approved Starjemza (ustekinumab-hmny), a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

For patients evaluated for acute coronary syndrome, replacing sedentary behavior with sleep, light-intensity physical activity, or moderate- to vigorous-intensity physical activity is associated with ...

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

Transcutaneous auricular vagus nerve stimulation (tVNS) may be a safe pain-relieving treatment for people with knee osteoarthritis (OA).

Dry eye disease metrics, such as NIBUT and MG dropout, may serve as predictive biomarkers for possible thyroid disorders.